As a physician, scientist, technologist, drug developer, investor, I’ve accumulated my share of experience+perspective, which I recently had the chance to distill+share as a guest on a new podcast series out of Harvard Business School. Here are my 12 take-aways on data, digital, DNA, and pharma.
The Digital Dozen: My 12 Takeaways for HBS On Data, DNA, And Pharma
